introduct
ii
narcissu
alkaloid
occurr
iii
biosynthet
pathway
iv
synthet
studi
v
spectroscopi
alkaloid
data
refer
genu
narcissu
l
belong
narcissea
one
tribe
amaryllidacea
wide
distribut
monocotyledon
famili
genera
speci
amaryllidacea
richli
repres
tropic
pronounc
center
divers
south
africa
andean
region
genera
also
found
mediterranean
area
temper
region
asia
famili
phylogenet
relationship
close
follow
geograph
distribut
much
region
endem
add
credenc
gondwana
origin
famili
time
contin
much
closer
togeth
hypothesi
famili
evolv
africa
subsequ
spread
contin
sug
gest
south
america
center
secondari
diversif
support
matk
sequenc
data
narcissu
compris
approxim
wild
speci
perenni
geo
phyte
geograph
concentr
southwestern
europ
center
divers
iberian
peninsula
north
africa
substanti
hypo
these
landmass
europ
africa
join
speci
extend
franc
itali
even
fewer
found
balkan
eastern
mediterranean
record
outsid
area
n
tazetta
variant
china
japan
almost
certainli
ancient
introduct
nativ
habitat
narcissu
speci
vari
rang
lowland
mountain
site
includ
grassland
scrub
wood
river
bank
rocki
crevic
speci
amaryllidacea
amaryllidacea
alkaloid
therefor
includ
alliacea
famili
furthermor
although
unusu
find
type
alkaloid
famili
present
alway
accom
pani
typic
amaryllidacea
alkaloid
classic
exampl
report
presenc
mesembran
sceletium
alkaloid
gener
found
aizoacea
famili
speci
amaryllidacea
hymenoc
arenicola
crinum
oliganthum
n
pallidulu
n
triandru
turn
unexpect
isol
capnoidin
bulbocapnin
galanthu
nivali
subsp
cilicicu
first
report
occurr
classic
isoquinolin
alkaloid
typic
member
amaryllidacea
contrari
isol
amaryllidacea
alkaloid
crinamin
wild
yam
dioscorea
dregeana
dioscoreacea
also
proven
amaryllidacea
alkaloid
may
well
encount
plant
famili
result
suggest
definit
amaryllidacea
alkaloid
reconsid
also
alkaloid
profil
plant
famili
presenc
alkaloid
plant
believ
protect
adapt
amaryllidacea
connect
season
cycl
develop
mani
speci
grow
earli
spring
genera
start
grow
thu
amaryllidacea
plant
present
ontogen
variat
alkaloid
effect
stress
incision
injuri
insect
attack
alkaloid
metabol
caus
almost
complet
hydrolysi
alkaloid
conjug
also
produc
oxid
metabolit
regard
coevolutionari
adapt
notabl
exampl
elabor
new
conjug
alkaloid
telastasin
insect
polytela
gloriosa
fab
noctuida
smokeygray
moth
adapt
toxic
amaryllidacea
plant
plant
insect
use
detoxif
mech
anism
alkaloid
essenti
plant
surviv
wide
rang
interest
physiolog
effect
includ
antitumor
antivir
acetylcholinesteras
inhibitori
immunostimulatori
antimalari
activ
particular
interest
potenti
use
clinic
therapi
plant
amaryllidacea
famili
use
thousand
year
herbal
remedi
alkaloid
extract
object
activ
chemic
investig
nearli
year
past
two
decad
mani
isol
screen
differ
biolog
activ
synthes
number
research
group
import
handicap
avail
alkaloid
obtain
minut
quantiti
natur
sourc
sinc
isol
larger
quantiti
practic
strong
case
devel
opment
synthes
semisynthes
alkaloid
deriv
potenti
prodrug
histori
amaryllidacea
alkaloid
structur
elucid
biolog
profil
well
synthesi
summar
sever
occas
togeth
regular
public
journal
natur
product
report
repres
valuabl
sourc
inform
present
review
provid
coverag
isol
spectroscopi
biolog
cal
activ
chemic
synthesi
amaryllidacea
alkaloid
present
genu
narcissu
juli
numer
alkaloid
isol
narcissu
speci
result
continu
search
novel
alkaloid
pharmacolog
activ
amaryllidacea
famili
alkaloid
isol
genu
classifi
relat
differ
skeleton
type
shown
tabl
ivii
tabl
viii
list
differ
narcissu
wild
speci
intersect
hybrid
group
sub
genera
section
correspond
alkaloid
arrang
accord
ring
system
occurr
alkaloid
narcissu
cultivar
shown
tabl
ix
presenc
almost
alkaloid
genu
tabl
ivii
mean
approxim
third
total
number
alkaloid
isol
amaryllidacea
found
genu
narcissu
amaryllidacea
alkaloid
present
speci
varieti
narcissu
studi
gener
seri
relat
alkaloid
found
plant
often
major
metabolit
sever
minor
compon
differ
posit
substitut
wild
speci
around
cultivar
studi
relat
presenc
alkaloid
tabl
viii
ix
mean
half
narcissu
speci
varieti
still
explor
aspect
alkaloid
lycorin
homolycorin
group
whole
common
alkaloid
genu
lycorin
galanthin
pluviin
lycorin
type
homolycorin
lycorenin
homolycorin
type
particularli
frequent
lycorin
abund
presenc
alkaloid
signific
section
narcissu
mainli
lycorin
type
pseu
donarcissi
mainli
homolycorin
type
tazetta
wild
speci
divis
cultivar
almost
lycorinetyp
alkaloid
isol
narcissu
present
transunion
bc
ring
make
especi
vulner
oxid
process
interest
observ
four
alkaloid
name
vasconin
tortuosin
ungeremin
roserin
possess
unusu
qua
ternari
nitrogen
speci
n
pallidulu
section
ganymed
unusu
contain
mesembranetyp
alkaloid
even
except
due
presenc
roserin
alkaloid
homolycorin
seri
form
restructur
lycorinetyp
alkaloid
absent
tribe
amaryllidacea
amaryllidea
hemanthea
reason
presenc
alkaloid
distinct
featur
narcissea
tribe
moreov
narcissu
alkaloid
homolycorin
seri
display
bc
ring
junction
ci
stereo
chemistri
except
homolycorinetyp
alkaloid
dubiusin
unusu
hydroxybutyryl
substitu
main
group
alkaloid
origin
parapara
oxid
phenol
coupl
omethylnorbelladin
hemanthamin
tazettin
narciclasin
type
frequent
repres
genu
model
alkaloid
group
hemanthamin
tazettin
narciclasin
respect
presenc
signific
pseudonarcissi
tazetta
bulbocodii
section
wild
speci
divis
cultivar
hemanthaminetyp
alkaloid
abund
biogenet
sourc
type
lack
crininetyp
alkaloid
bridg
configur
genu
repres
bridg
seri
hemanthamin
type
signific
taxonom
featur
addit
narcissu
hemanthaminetyp
alkaloid
never
show
substitut
ar
omat
ring
posit
usual
crininetyp
alkaloid
tribe
amaryllidea
hemanthea
pair
alkaloid
hydroxyl
sub
tituent
like
hemanthidin
alway
appear
mixtur
epim
solut
also
interest
mention
unusu
structur
bujein
alkaloid
hemanthamin
type
modifi
bridg
heteroatom
acetoxymethyl
substitu
posit
ismin
consid
catabol
product
hemanthamin
seri
tazettin
wide
report
alkaloid
amaryllidacea
famili
particularli
narcissu
see
tabl
viii
ix
although
known
extract
artifact
pretazettin
alkaloid
tazettin
type
isol
narcissu
speci
show
typic
methylenedioxi
group
posit
obesin
except
tazettinetyp
alkaloid
sevenmemb
ring
narciclasin
reason
abund
narcissu
spp
serv
use
intermedi
synthet
convers
pancratistatin
see
section
iv
conduct
seri
structureact
relationship
studi
bicolorin
anoth
member
narciclasin
seri
unusu
complet
aromat
quaternari
alkaloid
nmethyl
group
montaninetyp
alkaloid
also
deriv
hemanthamin
seri
unusu
two
name
pancracin
nangustin
isol
two
speci
belong
narcissu
section
genu
nangustin
uniqu
substitut
pattern
first
alkaloid
substitut
instead
typic
galanthaminetyp
alkaloid
group
among
aryllidacea
alkaloid
show
two
ortho
aromat
proton
ring
type
alkaloid
often
show
nmethyl
group
occasion
nformyl
nacetyl
concentr
galanthamin
narcissu
found
vari
wide
speci
varieti
trace
amount
potenti
narcissu
cultivar
carlton
gigant
star
ice
folli
fortun
wild
speci
n
confusu
sourc
galanthamin
relat
alkaloid
recogn
research
initi
agronom
factor
affect
content
narcissu
two
import
advantag
leucojum
aestivum
first
bulb
mani
narcissu
cultivar
avail
commerci
quantiti
offer
possibl
establish
largescal
cultiv
short
time
second
comprehens
bodi
inform
alreadi
exist
regard
narcissu
propag
physiolog
breed
cultiv
mesembran
sceletium
type
alkaloid
also
present
narcissu
plant
noteworthi
alkaloid
group
mesembrenon
sembrenol
mesembrin
isol
narcissu
restrict
speci
ganymed
section
therefor
chemotaxonom
interest
gener
found
aizoacea
dicotyledon
famili
amaryllidacea
sceletiumtyp
alkaloid
common
biogenet
precursor
although
biosynthes
fundament
differ
also
two
unclassifi
alkaloid
name
cheryllin
pallidi
florin
cheryllin
tetrahydroisoquinolin
deriv
uniqu
repres
rare
phenol
amaryllidacea
alkaloid
pallidiflorin
heterobi
alkaloid
isol
n
pallidifloru
bisalkaloid
present
genu
isol
alkaloid
form
two
directli
join
moieti
one
alkaloid
lycoramin
galanthamin
type
revers
form
hemiacet
tazettin
well
establish
profil
alkaloid
vari
time
locat
development
stage
mani
instanc
site
biosynthesi
restrict
singl
organ
accumul
correspond
product
detect
sever
plant
tissu
longdist
transport
must
take
place
instanc
data
ontogen
variat
distribut
alkaloid
speci
amaryllidacea
famili
result
obtain
narcissu
speci
n
assoanu
lycorinetyp
alkaloid
n
confusu
alkaloid
homolycorin
hemanthamin
tazettin
galanthamin
type
veget
period
bulb
n
assoanu
lower
concen
tration
alkaloid
aerial
part
pseudolycorin
major
alkaloid
aerial
part
bulb
repres
around
total
alkaloid
synthesi
alkaloid
might
take
place
mainli
aerial
part
accu
mulat
flower
fecund
transport
bulb
seem
order
avoid
autotox
pseudolycorin
store
bulb
deriv
specif
local
alkaloid
make
sens
role
defens
andor
signal
compound
accept
rule
vulner
tissu
defend
old
senesc
tissu
galanthamin
four
alkaloid
n
confusu
found
present
organ
everi
stage
except
hemanthamin
occur
senesc
flower
main
alkaloid
galanthamin
follow
nformylnorgalanthamin
tazettin
depend
sampl
homolycorin
gener
least
common
organ
highest
total
alkaloid
accumul
throughout
ontogen
cycl
bulb
except
end
cycl
alkaloid
accumul
mainli
flower
stem
reach
concentr
dri
weight
biosynthet
research
done
amaryllidacea
alkaloid
carri
earli
sinc
noteworthi
studi
biosynthesi
galanthamin
relat
alkaloid
alkaloid
biosynthes
amaryllidacea
follow
sequenti
pattern
although
lphenylalanin
lphe
ltyrosin
ltyr
close
relat
chemic
structur
interchang
plant
amaryllidacea
alkaloid
lphe
serv
primari
precursor
c
c
frag
ment
correspond
ring
benzyl
posit
ltyr
precursor
ring
c
twocarbon
side
chain
nitrogen
c
c
n
convers
lphe
c
c
unit
requir
loss
two
carbon
atom
side
chain
well
introduct
least
two
oxygen
substitu
aromat
ring
perform
via
cinnam
acid
presenc
enzym
phenylalanin
ammonia
lyas
pal
demonstr
amaryllidacea
plant
elimin
ammonia
mediat
enzym
known
occur
antiperiplanar
manner
give
transcinnam
acid
loss
bpro
hydrogen
thu
may
expect
lphe
would
incorpor
amaryllidacea
alkaloid
retent
bpror
hydrogen
howev
feed
experi
narcissu
king
alfr
show
tritium
origin
present
cb
lphe
whatev
configur
lost
format
sever
hemanthamineand
homolycorinetyp
alkaloid
led
conclus
fragment
cinnam
acid
involv
oxid
cb
keton
acid
level
final
product
protocatechu
aldehyd
deriv
fig
hand
ltyr
degrad
tyramin
incorpor
amaryllidacea
alkaloid
tyramin
protocatechu
aldehyd
deriv
logic
compo
nent
biosynthesi
precursor
norbelladin
pivot
reaction
tabl
ivii
repres
entri
primari
metabolit
secondari
metabol
pathway
junction
amin
aldehyd
result
schiff
base
two
isol
sever
crinum
speci
craugsodin
isocraugsodin
exist
schiff
base
natur
well
easi
convers
differ
ring
system
amaryllidacea
alkaloid
suggest
initi
hypothesi
biosynthet
pathway
correct
barton
cohen
propos
norbelladin
relat
alkaloid
could
undergo
oxid
coupl
amaryllidacea
plant
ring
suitabl
protect
methyl
result
differ
skeleton
amaryllidacea
alkaloid
fig
alkaloid
group
deriv
pyrrolo
de
phenanthridin
lycorin
type
indol
homolycorin
type
skeleton
type
origin
orthopara
phenol
oxid
coupl
fig
biolog
convers
cinnam
acid
via
hydroxyl
cinnam
acid
c
c
unit
norpluviin
use
studi
hydroxyl
mechan
higher
plant
h
c
cinnam
acid
fed
narcissu
texa
tritium
retent
norpluviin
observ
close
predict
valu
result
parahydroxyl
hydrogen
migrat
retent
convers
omethylnorbelladin
lycorin
label
posit
h
aromat
ring
ltyr
afterward
appear
norpluviin
form
intermedi
configur
tritium
appar
b
tritium
retain
subsequ
form
lycorin
mean
hydroxyl
proce
invers
configur
mechan
involv
epoxid
ring
open
follow
allyl
rear
rangement
result
alcohol
fig
support
evid
come
incorpor
h
caranin
lycorin
zephyranth
candida
howev
hydroxyl
caranin
clivia
miniata
occur
retent
configur
also
observ
c
caranin
incorpor
lycorin
high
retent
tritium
indic
implic
intermedi
convers
omethoxyphenol
methylenedioxi
group
may
occur
late
biosynthet
pathway
tritiat
norpluviin
convert
tritiat
lycorin
narcissu
deanna
durbin
demonstr
previous
mention
convers
also
indic
hydroxyl
group
lycorin
deriv
allyl
oxid
either
norpluviin
caranin
regard
convers
c
pluviin
galanthin
narcissu
king
alfr
retent
tritium
label
confirm
hydroxyl
may
occur
invers
configur
consid
anoth
analog
epoxid
could
give
nar
cissidin
way
shown
loss
pro
hydrogen
galanthin
suitabl
substrat
epoxid
label
c
h
omethylnor
belladin
fed
narcissu
sempr
avanti
afford
galanthin
tritium
retent
narcissidin
tritium
retent
loss
hydrogen
galanthin
therefor
stereospecif
kihara
et
al
isol
new
alkaloid
incartin
flower
lycori
incarnata
could
consid
biosynthet
intermedi
pathway
fig
biolog
convers
protocatechu
aldehyd
lycorenin
proce
via
omethylnorbelladin
norpluviin
first
involv
reduct
aldehyd
carbonyl
afterward
gener
lycorenin
oxid
carbon
atom
absolut
stereochemistri
process
elucid
subsequ
experi
result
show
hydrogen
addit
remov
take
place
refac
molecul
concern
initi
introduc
hydrogen
one
later
remov
noteworthi
norpluviin
unlik
pluviin
convert
narcissu
king
alfr
primarili
alkaloid
homolycorin
type
benzyl
oxid
posit
would
afford
follow
ring
open
form
amino
aldehyd
hemiacet
format
methyl
could
provid
lycorenin
subsequ
oxid
could
afford
homolycorin
shown
fig
group
includ
alkaloid
deriv
crinin
hemanthamin
type
indol
tazettin
type
phenanthridin
narciclasin
type
montanin
type
skeleton
origin
parapara
phenol
oxid
coupl
fig
result
experi
label
crinin
less
conclus
oxovittatin
indic
two
natur
occur
enantiomer
seri
repr
sent
fig
crinin
vittatin
interchang
nerin
bowdenii
label
methoxi
carbon
also
posit
h
alkaloid
hemanthamin
without
loss
tritium
half
site
consider
possibl
mechan
involv
relat
tritium
retent
led
suggest
tritium
expect
might
stereospecif
convers
omethylnorbelladin
hemanthamin
involv
loss
pror
hydrogen
cb
tyramin
moieti
well
entri
hydroxyl
group
site
subsequ
benzyl
oxid
result
epimer
mixtur
even
hplc
separ
epimer
form
propos
interchang
biosynthet
convers
alkaloid
indol
demonstr
feed
tritiumlabel
alkaloid
sprekelia
formosissima
shown
plant
convert
hemanthamin
hemanthidineepihemantha
mine
subsequ
pretazettin
essenti
irrevers
manner
transform
consid
proceed
relat
alkoxid
anion
although
intermedi
never
detect
spectral
method
fig
also
prove
format
alkaloid
narciclasin
pro
ceed
pathway
crinineand
hemanthaminetyp
alkaloid
norpluviin
lycorin
deriv
fact
view
structur
affin
hemanthamin
lycorin
narciclasin
could
deriv
either
pathway
omethylnorbelladin
label
methoxi
carbon
proton
posit
tyramin
aromat
ring
administ
narcissu
plant
four
alkaloid
incorpor
activ
isotop
ratio
h
c
norpluviin
lycorin
expect
precursor
orthopara
coupl
contrari
hemanthamin
ratio
unchang
result
show
clearli
methoxi
group
complet
retain
alkaloid
mention
provid
satisfactori
intern
standard
show
degre
tritium
retent
reliabl
guid
direct
phenol
coupl
narciclasin
show
isotop
ratio
higher
lycorin
norpluviin
though
lower
hemanthamin
howev
fact
tritium
retain
suggest
omethylnorbelladin
incorpor
narciclasin
via
parapara
phenol
oxid
coupl
omethylnorbelladin
vittatin
implic
intermedi
biosynthesi
narciclasin
loss
ethan
bridg
figur
biosynthesi
pretazettin
latter
could
occur
retroprin
reaction
strong
support
pathway
obtain
label
studi
tine
also
propos
intermedi
biosynthesi
hema
nthamin
montanin
alkaloid
follow
observ
specif
incorpor
vittatin
two
alkaloid
rhodophiala
bifida
fig
fuganti
mazza
conclud
late
stage
narciclasin
biosynthesi
twocarbon
bridg
lost
oxocrinin
skeleton
pass
intermedi
bear
pseudoaxi
hydroxygroup
posit
hydrogen
remov
posit
occur
noroxomaritidin
also
implic
biosynthesi
narciclasin
experi
show
also
precursor
ismin
alkaloid
ismin
also
shown
transform
product
crininehemanthamin
seri
precursor
oxocrinin
label
tritium
posit
administ
sprekelia
formosissima
plant
radioact
ismin
isol
shown
specif
label
expect
posit
alkaloid
dibenzofuran
nucleu
galanthamin
type
obtain
paraortho
phenol
oxid
coupl
initi
studi
pathway
suggest
paraortho
coupl
proceed
omethylnorbelladin
n
odimethylnorbella
dine
final
give
galanthamin
ndimethylnorbelladin
first
isol
pancratium
maritimum
speci
also
contain
galanthamin
howev
recent
studi
seem
contradict
evid
set
forth
experi
carri
applic
clabel
omethylnorbella
dine
organ
fieldgrown
l
aestivum
shown
biosynthesi
galanthamin
involv
phenol
oxid
coupl
omethylnorbelladin
postul
dienon
undergo
spontan
closur
ether
bridg
yield
ndemethylnarwedin
give
norgalanthamin
stereoselect
reduct
furthermor
shown
norgalanthamin
nmethyl
galanthamin
final
step
biosynthesi
fig
contrast
literatur
n
odimethylnorbelladin
metabol
lesser
extent
l
aestivum
incorpor
galanthamin
well
norgala
nthamin
onethird
rate
omethylnorbelladin
accord
eichhorn
et
al
narwedin
direct
precursor
galanthamin
could
possibl
exist
equilibrium
galanthamin
reaction
catalyz
hypothet
revers
oxidoreductas
chlidanthin
analog
known
convers
codein
morphin
might
expect
aris
galanthamin
odemethyl
shown
true
galanthamin
narwedin
tritium
label
incorpor
chlidanthin
figur
biosynthesi
galanthamin
deriv
synthesi
narcissu
alkaloid
subject
intens
effort
past
year
exhaust
report
beyond
scope
chapter
reader
refer
recent
excel
review
field
thorough
account
sever
approach
total
synthesi
alkaloid
demonstr
effici
describ
herein
rep
resent
exampl
classifi
accord
mechanist
criteria
biomimet
oxid
phenol
coupl
still
stand
practic
method
prepar
alkaloid
new
synthes
narwedin
galanthamin
disclos
former
prepar
enantiopur
form
correspond
racem
crystallizationin
duce
chiral
transform
deriv
well
galanthamin
analogu
n
atom
alter
posit
aze
pine
ring
also
report
signific
improv
oxid
protocol
use
pifa
oxid
symmetr
substrat
allow
effici
synthesi
racem
narwedin
galanthamin
scheme
group
later
report
effici
rout
galanthamin
variat
method
wherebi
remot
asymmetr
induct
use
well
total
synthes
siculin
oxocrinin
epicrinin
buflavin
solidphas
version
biomimet
method
develop
context
diversityori
synthesi
gener
librari
galanthaminelik
molecul
allow
identif
compound
potent
new
blocker
protein
traffick
golgi
apparatu
plasma
membran
interestingli
galanthamin
exhibit
biolog
activ
new
oxid
rearrang
led
synthesi
lycoramin
relat
lewisacidpromot
transform
allow
prepara
tion
mesembrin
crinan
racem
form
impress
demonstr
use
solidsupport
reagent
scaveng
total
synthesi
natur
product
provid
group
ley
previou
work
see
ref
applic
new
methodolog
intend
expedit
synthet
rout
work
requir
protocol
involv
filtrat
follow
evapor
solvent
plica
mine
synthes
without
need
chromatographi
sequenc
start
phydroxyphenylglycin
upon
function
undergo
reduct
amin
piperon
result
product
subject
biomimet
phenol
oxid
coupl
solidsupport
iodonium
diacet
acidpromot
conjug
addit
close
lactam
ring
subsequ
function
group
tran
format
led
desir
product
everi
singl
step
use
solidsupport
reagent
solidsupport
scaveng
scheme
group
later
disclos
synthes
obliquin
plican
transit
metal
especi
palladium
use
stereoselect
synthesi
alkaloid
remark
success
sinc
overman
approach
tazettin
use
intramolecular
heck
reaction
methodolog
construct
critic
quaternari
stereogen
center
impl
ment
prepar
mani
alkaloid
grigg
later
report
access
r
r
crinan
via
regiospecif
palladiummedi
cycliz
effici
total
synthesi
racem
galanthamin
follow
approach
recent
disclos
key
intramolecular
heck
reaction
deprotect
relat
strategi
use
prepar
racem
maritidin
lycoramin
eleg
unifi
approach
synthes
pancracin
montanin
coccinin
brunsvigin
use
intramolecular
heck
reaction
ring
closur
central
azepin
ring
connect
bromoaren
termin
alken
moieti
key
precursor
prepar
via
stereospecif
intramolecular
allenylsilan
addit
imin
ender
recent
report
asymmetr
synthesi
aglycon
cripowel
in
b
base
intramolecular
heck
reaction
function
bromoarylazacyclononen
turn
prepar
via
ring
close
metathesi
openchain
precursor
buflavin
prepar
short
rout
assembl
biphenyl
intermedi
suzuki
coupl
recent
palladiumcatalyz
asymmetr
allyl
substitut
activ
cyclohexenol
deriv
allow
two
enantioselect
synthes
galantha
mine
approach
reli
enantioselect
prepar
tricycl
intermedi
subsequ
convert
alkaloid
via
stereocontrol
transform
effici
compris
stereos
lectiv
allyl
oxid
cyclohexen
moieti
scheme
methodo
logi
allow
synthesi
codein
morphin
group
earlier
report
synthesi
pancratistatin
follow
relat
strategi
use
tosylamid
nucleophil
displac
activ
arylcyclohexenol
deriv
enabl
prepar
chiral
intermedi
scheme
enantioselect
synthesi
galanthamin
sequenti
convert
crinamin
hemanthidin
pretazettin
regioselect
ch
activ
often
use
intramolecular
biaryl
prepar
pdmediat
transform
thu
concis
synthes
larg
collect
alkaloid
report
use
variat
approach
differ
mainli
term
function
precursor
palladium
catalyst
ligand
effici
synthesi
racem
glycoran
recent
disclos
wherebi
key
step
intramolecular
aaryl
cyclo
hexanon
deriv
heterocycl
synthet
precursor
eg
substitut
indol
quinolin
quinolon
phenanthridin
phenanthridinon
also
prepar
en
rout
alkaloid
hippadin
trisphaeridin
crin
asiadin
via
pdand
cumedi
reaction
use
main
group
metal
also
facilit
alkaloid
synthesi
exem
plifi
prepar
brunsvigin
intramolecular
anion
cycliz
addit
organolithium
deriv
amid
also
meyer
biaryl
coupl
use
key
step
total
synthesi
buflavin
connect
direct
ortho
metal
crosscoupl
reaction
basi
eleg
synthes
buflavin
pratosin
hippadin
synthesi
mesembrin
achiev
rout
involv
stereoselect
ring
open
arylsubstitut
epoxid
grignard
reagent
develop
enzymat
dihydroxyl
aromat
enabl
synthet
access
larg
collect
cyclohexadien
diol
enantiopur
form
compound
becom
invalu
synthet
materi
pivot
intermedi
total
synthes
structur
divers
natur
product
particular
group
hudlicki
develop
methodolog
devis
short
effici
enantioselect
total
synthes
alkaloid
relat
com
pound
meet
quantiti
demand
materi
use
biolog
studi
lycorici
dine
prepar
nine
step
bromobenzen
start
materi
use
straightforward
synthes
pancratistatin
deriv
recent
hudlicki
group
publish
synthesi
narciclasin
base
wholecel
ferment
recombin
escherichia
coli
scheme
result
dienediol
subject
heterodielsald
reaction
nitroso
deriv
correspond
adduct
underw
suzuki
coupl
follow
reduct
open
oxazin
bond
stereoselect
reduct
result
keton
exchang
acetonid
moieti
acet
group
bischlernapieralskityp
ring
closur
remov
ester
phenol
methyl
protect
group
led
desir
product
group
also
disclos
synthesi
via
azapayn
rearrang
scheme
analogu
narciclasin
pan
crastistatin
synthes
use
modif
report
procedur
well
new
methodolog
eg
addit
indol
oxiran
aziridin
deriv
cyclohexadien
diol
pancratistatin
analogu
carbohydratederiv
structur
place
polyhydroxycyclohexan
moieti
prepar
studi
minimum
pharmacophor
parent
molecul
wellestablish
radic
reaction
use
drive
select
con
nectiv
often
without
need
protect
group
normal
requir
polar
approach
also
live
natur
radic
addit
trigger
eleg
effici
reaction
cascad
format
multipl
cc
bond
group
magnu
continu
exploit
bazidon
reaction
silyl
enol
ether
use
synthesi
pancratistatin
appli
type
approach
synthesi
lycoran
deriv
pyrrolidin
ring
close
via
cobaltpromot
intramolecular
radic
additiondehydrogen
reaction
parson
report
model
studi
cycliz
divers
substitut
deriv
yield
octahydroindol
deriv
relat
amaryllidacea
alkaloid
process
radic
cycliz
promot
tributyltin
hydrid
samarium
ii
iodid
manganes
iii
acet
curran
report
radic
cycliz
lead
spirocyclohexadienon
includ
formal
synthesi
azagalanthamin
keck
report
impress
radic
cascad
process
crucial
step
total
synthesi
modifi
approach
led
synthesi
lycoricidin
via
substitut
alkenyl
radic
oxim
ether
scheme
precursor
prepar
dgulonolacton
protect
select
transform
coupl
sonogashira
reaction
substitut
iodoaren
yield
key
alkyn
intermedi
phsh
ad
photochem
activ
gener
vinyl
radic
ad
oxim
ether
moieti
close
sixmemb
ring
high
stereoselect
treatment
result
com
pound
smi
allow
cleavag
bond
remov
thioether
format
lactam
final
step
deprotect
acetonid
group
entlycoricidin
narciclasin
formal
synthesi
racem
pancracin
via
radic
cycliz
n
aphenylthioacetamid
report
racem
monta
nine
coccinin
pancracin
prepar
use
phenyl
thiotetrahydroisoquinolin
deriv
radic
precursor
recent
zard
describ
construct
carbon
skeleton
kirkin
model
studi
thiosemicarbazid
prorad
interact
lauroyl
peroxid
tinfre
initi
trigger
reaction
cascad
ultim
yield
desir
tetracycl
system
kirkin
interest
csp
csp
coupl
via
aryl
radic
cycliz
use
key
step
unifi
strategi
synthes
vasconin
assoanin
oxoassoanin
pratosin
tin
hydrid
cycliz
n
obromobenzyl
anilin
yield
substitut
phenanthridin
subsequ
transform
vasconin
remain
natur
product
prepar
scheme
azacopemannich
cycliz
protocol
develop
overman
strateg
appli
synthesi
racem
enantiopur
pancracin
assoanin
oxoassoanin
p
r
n
e
rearrang
key
step
stereoselect
synthesi
racem
pancratista
tin
hornerwasdsworthemmon
reaction
provid
reactiv
olefin
upon
heat
afford
rearrang
aryl
cyclohexenylcarbaldehyd
turn
oxid
correspond
acid
subject
halolacton
elimin
protocol
yield
unsatur
lacton
intermedi
convert
hydroxyest
subsequ
functionalgroup
transform
allow
stereocontrol
instal
remain
stereogen
center
final
ring
closur
sequenc
end
deprotect
ester
methyl
phenol
group
scheme
rigbi
studi
synthesi
alkenylisocyan
foster
prepara
tion
suitabl
substitut
aryl
enamid
photocycl
yield
polysubstitut
pentacycl
system
key
success
process
hydro
gen
bond
phenol
oh
carbonyl
group
restrict
rotat
around
arylamid
bond
direct
cycliz
function
aliz
allow
total
synthesi
pancratistatin
narciclasin
scheme
cycloaddit
bi
alkylthio
carben
vinyl
isocyan
key
process
recent
synthesi
mesembrin
dielsald
cycloaddit
play
import
role
synthesi
narcissu
alkaloid
relat
structur
boger
prepar
anhydrolycorinon
use
intramolecular
heterodielsald
reaction
scheme
synthesi
glycoran
epizephyranthin
carbam
result
adduct
elabor
divers
substitut
hydroindolinon
via
nitrogenassist
ring
open
rh
ii
promot
nucleophil
reaction
former
provid
compound
subs
quent
transform
yield
glycoran
racem
wherea
latter
afford
materi
prepar
epizephyranthin
scheme
haseltin
describ
enantioselect
formal
synthesi
pancratistatin
stereocontrol
driven
acetonid
conduritol
enantio
select
hydrolysi
desymmetr
compound
achiev
lipas
arylcyclohexan
ring
bond
form
intramolecular
cycliz
activ
benzen
ring
allyl
triflat
plumet
report
total
synthesi
base
conjug
addit
aryllithium
speci
bicycl
conjug
sulfon
deriv
furan
enabl
effici
instal
six
stereogen
center
cyclohexan
ring
scheme
next
seri
synthes
base
conjug
addit
hexanon
regioand
stereoselect
ad
nitroethylen
access
octahydroindol
core
present
alkaloid
enabl
total
synthesi
glycoran
crinan
tomioka
describ
chemoselect
conju
gate
addit
nitro
michael
reaction
sequenc
prepar
aand
blycoran
racem
form
addit
arylcupr
dmannitolderiv
conjug
ester
provid
access
synthet
precursor
amaryllidacea
alkaloid
similarli
addit
arylcupr
enantiomer
pure
conjug
ester
deriv
dxylos
allow
pertin
fg
transform
ringclos
metathesi
prepar
novel
f
compound
advanc
intermedi
en
rout
pancratistatin
deriv
synthesi
racem
mesembrin
featur
intramolecular
addit
amin
cyclohexenon
moieti
close
octahydroindolon
ring
system
recent
disclos
taber
describ
eleg
approach
mesembrin
reli
conjug
addit
intramolecular
alkyliden
ch
insert
intramolecular
addit
nacyliminium
ion
gener
pummer
reaction
use
prepar
highli
function
tricycl
intermedi
synthesi
put
alkaloid
jamtin
synthesi
cheryllin
enantiopur
form
achiev
use
chiral
auxiliari
sequenc
involv
reduct
aminationacidpromot
cycliz
short
synthes
enantiomer
pure
narciclasin
lycoricidin
base
intramolecular
acidcatalyz
areneepoxid
coupl
describ
bromohydroxyl
protect
aminocyclohexenol
af
ford
correspond
bromohydrin
mixtur
two
tran
stereoisom
subsequ
transform
link
arylmethyl
moieti
basic
medium
concomit
format
epoxid
ring
therebi
set
stage
crucial
carboncarbon
bond
format
requir
cycliz
subsequ
func
tional
group
transform
exchang
protect
group
oxid
ben
zylic
posit
final
deprotect
afford
lycoricidin
scheme
narciclasin
prepar
follow
relat
pathway
group
also
report
conveni
approach
chiral
oisopropylideneprotect
take
advantag
avail
narciclasin
plant
extract
pettit
use
compound
start
materi
effici
synthesi
pan
cratistatin
group
also
describ
relat
approach
prepar
pancratistatin
phosphat
prodrug
well
natur
product
relat
deriv
anoth
context
improv
protocol
synthesi
galanthamin
base
spontan
resolut
either
enantiom
narwedin
report
short
rout
enantiomer
pure
lacton
analogu
narciclasin
lycoricidin
use
dgulonolacton
chiral
pool
sourc
contain
stereogen
center
product
correct
configur
connect
function
aryl
moieti
aris
addit
organolithium
reagent
carbonyl
group
gulonolacton
total
synthes
heman
thidin
pretazettin
tazettin
start
amethyldmannopyranosid
vittatin
pre
pare
dglucos
sequenc
involv
ferrier
carbocycl
yield
cyclohexenon
deriv
function
claisen
rearrang
gave
intermedi
quaternari
carbon
atom
requir
stereo
chemistri
closur
aryloctahydroindol
ring
system
provid
desir
product
quinic
acid
effici
use
synthet
precur
sor
incorpor
aminocyclohexanetriol
moieti
present
scheme
follow
discuss
proton
nuclear
magnet
reson
h
nmr
carbon
nuclear
magnet
reson
c
nmr
mass
spectrometri
ms
narcissu
alkaloid
list
differ
narcissu
alkaloid
spectroscop
properti
literatur
recent
spectroscop
data
given
tabl
x
proton
nuclear
magnet
reson
h
nmr
spectroscopi
give
import
inform
differ
type
amaryllidacea
alkaloid
last
two
decad
routin
use
nmr
techniqu
facilit
structur
assign
establish
stereochemistri
compil
differ
h
nmr
spectra
arrang
accord
ing
differ
skeleton
type
shown
tabl
xixvii
group
subject
sever
h
nmr
studi
lycorin
well
main
deriv
complet
assign
gener
characterist
h
nmr
spectra
alkaloid
list
numer
order
group
accord
ring
system
see
tabl
ivii
two
singlet
paraori
aromat
proton
togeth
uniqu
olefin
proton
b
two
doublet
ab
system
correspond
benzyl
proton
deshield
observ
bproton
posit
relat
ahomologu
due
effect
cislon
pair
nitrogen
atom
c
like
almost
lycorinetyp
exampl
alkaloid
isol
narcissu
genu
show
tran
bc
ring
junction
coupl
constant
j
hz
kirkin
show
ci
bc
ring
junction
smaller
coupl
constant
j
hz
plant
alkaloid
lycorin
particularli
vulner
oxid
process
give
sever
ringc
aromat
product
group
includ
lacton
hemiacet
unusu
cyclic
ether
alkaloid
gener
trait
type
alkaloid
summar
follow
two
singlet
paraori
aromat
proton
lacton
alkaloid
deshield
caus
pericarbonyl
group
b
hemiacet
alkaloid
alway
show
substitu
adisposit
c
major
alkaloid
belong
singl
enantiomer
seri
contain
ci
bc
ring
junction
congruent
small
size
coupl
constant
j
narcissu
genu
except
rule
observ
larg
coupl
constant
j
hz
consist
transdiaxi
relationship
e
gener
ring
c
present
vinyl
proton
posit
substitut
oh
ome
oac
group
alway
display
adisposit
f
singlet
correspond
nmethyl
group
rang
ppm
absenc
unusu
g
deshield
consequ
cislon
pair
nitrogen
atom
homolycorinetyp
alkaloid
satur
ring
c
studi
jeff
cowork
describ
empir
correl
nmethyl
chemic
shift
stereochem
assign
bc
cd
ring
junction
absolut
configur
alkaloid
determin
cir
cular
dichroism
spectrum
alkaloid
narcissu
genu
exclus
hemanthamin
type
genera
brunsvigia
boophan
etc
crinin
type
alkaloid
predomin
also
noteworthi
alkaloid
isol
narcissu
genu
show
addit
substitut
aromat
ring
apart
contrari
genera
crininetyp
alkaloid
predomin
presenc
alkaloid
methoxi
substitu
quit
common
thu
hemanthaminetyp
alkaloid
show
follow
characterist
two
singlet
paraori
aromat
proton
b
use
cdcl
solvent
magnitud
coupl
constant
olefin
proton
give
inform
configur
substitu
thu
alkaloid
twocarbon
bridg
ci
substitu
show
allyl
coupl
j
hz
show
smaller
coupl
j
hz
occur
crinamin
contrari
correspond
epimer
seri
eg
hemanthamin
larger
coupl
j
hz
shown
coupl
detect
c
frequent
addit
coupl
equatori
wmechan
proton
show
larg
coupl
j
hz
due
transdiaxi
disposit
characterist
hemanthamin
seri
two
doublet
ab
system
correspond
benzyl
proton
posit
e
pair
alkaloid
hydroxi
substitu
like
papyramin
etc
appear
mixtur
epim
separ
even
hplc
f
also
relat
posit
interest
note
ismin
catabol
product
hemanthamin
seri
show
restrict
rotat
around
biaryl
bond
make
methylen
proton
benzyl
posit
magnet
nonequival
although
tazettin
one
wide
report
alkaloid
amaryllidacea
famili
found
extract
artifact
pretazettin
presenc
nmethyl
group
ppm
tazettinetyp
alkaloid
immedi
distinguish
hemanthamin
type
proceed
biosynthet
moreov
h
nmr
spectrum
alway
show
signal
correspond
methylenedioxi
group
also
includ
alkaloid
obesin
group
although
exhibit
structur
differ
skeleton
type
among
amaryllidacea
alkaloid
galanthamin
type
show
orthocoupl
constant
aromat
proton
ring
gener
characterist
h
nmr
spectra
two
doublet
two
orthoori
aromat
proton
coupl
con
stant
j
hz
b
assign
substitu
stereochemistri
made
relat
coupl
constant
olefin
proton
coupl
constant
j
hz
substitu
pseudoaxi
hz
indic
substitu
pseudoequatori
c
two
doublet
ab
system
correspond
benzyl
proton
exist
furan
ring
result
deshield
effect
e
type
alkaloid
often
show
nmethyl
group
occasion
nformyl
group
report
b
carbon
nuclear
magnet
reson
c
nmr
spectroscopi
extens
use
determin
carbon
framework
amaryllidacea
alkaloid
sever
major
contribut
preliminari
assign
made
basi
chemic
shift
multipl
signal
dept
experi
use
nmr
tech
niqu
hmqc
hmbc
allow
assign
corrobor
tabl
xviiixxiv
show
compil
differ
c
nmr
spectra
classifi
accord
differ
type
c
nmr
spectra
narcissu
alkaloid
divid
two
region
lowfield
region
ppm
contain
signal
carbonyl
group
olefin
aromat
carbon
well
methylenedioxi
group
signal
correspond
satur
carbon
reson
found
highfield
region
nmethyl
characterist
group
easili
recogniz
quartet
signal
ppm
effect
substitu
oh
ome
oac
carbon
reson
consider
import
local
posit
function
group
analysi
spectra
allow
conclus
drawn
follow
aspect
number
methin
olefin
carbon
presenc
natur
nitrogen
substitu
mhz
exist
lacton
carbonyl
group
presenc
quaternari
carbon
signal
assign
chemic
shift
rang
ppm
extens
studi
mass
spectrometri
amaryllidacea
alkaloid
electron
impact
report
fragment
pattern
electron
impact
mass
spectrometri
eim
variou
skelet
type
fairli
well
document
consider
diagnost
valu
molecular
ion
appear
quit
intens
peak
gener
suffer
loss
water
well
substitu
retrodielsald
fragment
fig
loss
water
present
spectra
acetyl
deriv
eas
loss
water
molecular
ion
found
greatli
depend
stereochemistri
hydroxyl
group
thu
mass
spectrum
lycorin
rel
intens
low
base
peak
type
structur
cleavag
labil
bond
ring
c
retrodielsald
reaction
domin
gener
two
fragment
one
characterist
repres
pyrrolidin
ring
togeth
substitu
posit
lessabund
fragment
encompass
aro
matic
lacton
hemilacton
moieti
fig
gener
noteworthi
featur
low
abund
molecular
ion
alkaloid
doubl
bond
follow
observ
type
alkaloid
consid
case
molecular
ion
base
peak
ii
aromat
ring
play
import
role
stabil
ion
retain
fragment
high
mass
nitrogen
atom
often
lost
iii
fragment
mechan
initi
ruptur
bond
b
nitrogen
atom
impli
open
bridg
alkaloid
satur
ring
c
bridg
substitu
configur
ring
c
substitu
play
minor
role
fragment
process
b
alkaloid
doubl
bond
ring
c
bridg
substitu
fragment
pattern
involv
ruptur
bond
characterist
featur
loss
nitrogencontain
moieti
c
h
n
c
alkaloid
doubl
bond
ring
c
hydroxyl
substitu
presenc
hydroxyl
group
respons
dramat
chang
fragment
pattern
fig
profoundli
influenc
stereo
chemistri
three
fundament
pattern
fragment
loss
ch
oh
favor
twocarbon
bridg
substitu
side
molecul
minor
chang
stereochemistri
suffici
caus
appreci
differ
stereoisom
kind
structur
thu
ms
tazettin
bconfigur
methoxyl
group
domin
ion
occur
mz
follow
cring
fragment
retrodielsald
process
contrast
mass
spectrum
epim
criwellin
contain
peak
low
abund
mz
fig
ion
occur
stereoisom
owe
success
loss
methyl
radic
water
molecular
ion
mass
spectral
fragment
pattern
observ
alkaloid
contain
nucleu
greatli
depend
natur
par
ticular
configur
substitu
thu
alkaloid
possess
methoxyl
group
give
rise
ion
configur
substitu
consider
effect
extent
retrodielsald
fragment
ion
observ
fig
definit
enhanc
fragment
aconfigur
type
structur
intens
molecular
ion
well
peak
break
ring
c
lose
c
h
fragment
elimin
element
ring
b
includ
nitrogen
atom
characterist
fig
behavior
similar
dihydro
deriv
tradit
use
consid
narcissu
speci
rich
sourc
alkaloid
surpris
despit
lethal
potenti
plant
genu
use
throughout
histori
tradit
medicin
treat
varieti
medicin
problem
n
poeticu
exampl
describ
bibl
wellestablish
treat
ment
symptom
would
defin
cancer
fourth
centuri
bc
hippocr
co
father
medicin
recommend
pessari
prepar
narcissu
oil
probabl
n
poeticu
manag
uterin
tumor
first
centuri
ad
plini
elder
also
record
topic
use
n
poeticu
n
pseudonarcissu
purpos
known
n
poeticu
contain
antineoplast
agent
narciclasin
fresh
bulb
arabian
north
african
chines
medic
practition
middl
age
continu
use
narcissu
oil
cancer
treatment
exampl
bulb
n
tazetta
l
var
chinensi
cultiv
china
decor
plant
use
topic
treatment
tumor
folk
medicin
case
pretazettin
establish
one
antitumor
activ
compound
bulb
n
tazetta
continu
use
turkey
home
remedi
treatment
abscess
antiphlogist
analges
properti
narcissu
speci
also
use
applic
wound
hard
im
posthum
strain
sinew
stiff
pain
joint
local
ailment
basi
ancient
ointment
call
narcissimum
powder
flower
use
emet
form
syrup
infus
consid
use
reliev
congest
bronchial
catarrh
children
also
epidem
dysenteri
franc
narcissu
flower
use
antispasmod
arabian
commend
oil
cure
bald
aphrodisiac
john
keogh
irish
herbal
root
pound
honey
recom
mend
treat
burn
bruis
sinew
disloc
old
ach
remov
freck
le
heal
abscess
sore
draw
thorn
splinter
bulb
n
tazetta
also
use
contracept
influenc
daffodil
nervou
system
led
use
flower
bulb
hyster
affect
even
epilepsi
homeopath
medicin
also
made
bulb
use
respiratori
diseas
particularli
bronchiti
whoop
cough
plant
genu
use
throughout
histori
stimul
induc
tranc
hallucin
agent
suicid
socrat
call
narcissu
chaplet
infern
god
narcot
effect
plini
turn
describ
narcissu
narc
narcissum
dictum
non
fabuloso
puero
translat
mean
name
narcissu
narc
fabul
boy
greek
narkao
mean
numb
origin
narcot
properti
plant
known
long
time
daffodil
ingest
danger
result
toxic
symptom
man
warmblood
anim
cattl
goat
cat
pig
ingest
narcissu
speci
n
pseudonarcissu
n
jonquilla
first
visibl
symptom
saliv
acut
abdomin
pain
nausea
vomit
diarrhea
follow
neurolog
trembl
convuls
paralysi
etc
cardiac
sequel
sometim
result
death
eaten
larger
quantiti
mani
case
poison
death
bulb
cook
mistak
place
leek
onion
recoveri
howev
usual
complet
within
hour
without
treatment
necessari
case
massiv
ingest
activ
charcoal
salt
lax
administ
symptom
sever
atropin
sulphat
given
intraven
inject
may
necessari
induc
vom
ite
remov
stomach
content
good
news
bulb
tast
aw
make
highli
unlik
anyon
could
even
keep
one
bite
experi
perform
sever
plant
speci
consum
anim
plant
repel
activ
daffodil
specif
n
pseudonarcissu
consequ
anim
repel
contain
alkaloid
isol
member
genu
narcissu
design
repel
anim
veget
render
unpalat
also
effect
fungi
mold
bacteria
narcissu
speci
equal
danger
bulb
n
poeticu
exampl
danger
n
pseudonarcissu
neither
plant
tissu
concentr
profil
alkaloid
thu
alkaloid
content
n
papyraceu
five
time
higher
aerial
part
bulb
toxic
herbivor
mammal
distribut
alkaloid
plant
tissu
relat
plant
defens
mechan
narcissu
speci
n
pseudonarcissu
produc
harm
effect
without
swallow
thu
pick
pack
flower
liabl
develop
dermat
probabl
due
irrit
effect
sap
allerg
reaction
compound
respons
irrit
known
alkaloid
thought
involv
extract
bulb
appli
open
wound
produc
stagger
numb
whole
nervou
system
paralysi
heart
furthermor
scent
flower
speci
n
bulbocodium
produc
headach
even
vom
ite
place
confin
space
inde
mani
peopl
refus
daffodil
hous
consid
unlucki
way
hang
head
suggest
tear
unhappi
mucilag
secret
bulb
also
produc
harm
effect
plant
speci
rose
rice
cabbag
inhibit
seed
germin
seedl
growth
olfactori
qualiti
narcissu
flower
made
valuabl
compo
nent
luxuri
perfum
sinc
time
immemori
although
main
compon
volatil
part
narcissu
absolut
alkaloid
origin
ever
alkaloid
present
togeth
essenti
oil
narcissusderiv
perfum
jonquil
absolut
sever
narcissu
extract
shown
follow
activ
antivir
prophag
induct
antibacteri
antifung
antimalari
insecticid
cytotox
antitumor
antimitot
antiplatelet
hypoten
sive
emet
acetylcholin
esteras
inhibitori
antifertil
antinocicept
chronotrop
pheromon
plant
growth
inhibitor
allelopath
alkaloid
genu
narcissu
compound
respons
major
abovement
activ
although
mannosabind
lectin
also
receiv
much
interest
recent
spite
great
varieti
pharmacolog
andor
biolog
properti
exhibit
alkaloid
activ
reduc
number
report
extens
studi
effect
nonspecif
inhi
bition
relationship
chemic
structur
biolog
activ
larg
unknown
studi
need
explor
full
therapeut
potenti
alkaloid
moststudi
alkaloid
group
galanthamin
lycorin
narciclasin
pretazettin
possess
divers
pharmacolog
activ
lycorin
frequent
characterist
amaryllidacea
alkaloid
report
power
inhibitor
ascorb
acid
lasc
biosynthesi
thu
prove
use
tool
studi
ascdepend
metabol
reaction
lascsynthes
organ
lycorin
actual
power
inhibitor
activ
lgalactonoglacton
dehydrogenas
termin
enzym
lasc
biosynthesi
appear
local
mitochondri
membran
galanthin
also
high
capac
inhibit
ascorb
acid
biosynthesi
well
document
lycorin
power
inhibitor
cell
growth
cell
divis
organogenesi
higher
plant
alga
yeast
inhibit
cell
cycl
interphas
seem
relat
lasc
level
plant
also
inhibit
cyanideinsensit
respir
peroxidas
activ
protein
synthesi
effect
lycorin
lasc
biosyn
thesi
report
occur
concentr
protein
synthesi
affect
seem
difficult
complet
rule
nonspecif
effect
alkaloid
sinc
report
least
yeast
lycorin
abl
interact
directli
mitochondri
dna
thu
differ
sensit
alkaloid
among
cell
devoid
mitochondri
dna
rho
cell
mitochondri
dna
either
rho
rho
found
yeast
rho
cell
resist
high
concentr
drug
strain
even
adapt
presenc
lycorin
abl
degrad
alkaloid
use
biotransform
product
growthstimul
factor
hand
promot
cell
growth
seed
germin
rate
develop
root
root
hair
higher
plant
glucosyloxi
deriv
lycorin
pseudolycorin
agli
cone
form
stabl
complex
phytosterol
dival
metal
ion
abl
transloc
rhizospher
aerial
part
palmilycorin
acylglucosyloxi
conjug
lycorin
turn
frequent
encount
among
phytosterol
exhibit
membranestabil
action
addit
acylglucosyloxi
conjug
lycorin
use
plant
recognit
reject
vast
major
microorgan
parasit
anim
lycorin
show
antitumor
activ
report
hibit
vivo
vitro
growth
varieti
tumor
cell
mous
melanoma
lewi
lung
carcinoma
murin
ascit
hela
cell
induc
flat
morpholog
krasnrk
cell
transform
fibroblast
reduc
cellular
activ
femor
bone
marrow
tissu
result
granulocyt
leucopenia
decreas
number
erythrocyt
alkaloid
mechan
action
thought
inhibit
protein
synthesi
ribosom
level
even
though
cytotox
effect
calp
rotectin
also
suppress
use
lycorin
lycorin
also
inhibit
murin
macrophag
product
tumor
necrosi
factor
alpha
tnfa
show
inhibitori
effect
nitric
oxid
product
induct
induc
nitric
oxid
synthas
no
lipopolysaccharideactiv
macrophag
molecular
mechan
lycorin
leukemia
human
cell
line
show
suppress
cell
growth
reduc
cell
surviv
arrest
cell
cycl
phase
induc
apoptosi
tumor
cell
display
pronounc
cell
growth
inhibitori
activ
parent
multidrug
resist
mous
lymphoma
cell
line
almost
inact
inhibit
glycoprotein
respons
effluxpump
activ
tumor
cell
assay
interact
trna
reveal
antiprolif
effect
lycorin
result
complex
format
trna
interact
lycorin
pseudolycorin
dna
also
observ
alkaloid
seri
caranin
galanthin
pseudolycorin
also
activ
varieti
tumor
cell
pseudolycorin
inhibit
protein
synthesi
tumor
cell
step
peptid
bond
format
differ
bind
site
lycorin
ungeremin
natur
metabolit
lycorin
respons
least
part
growthinhibitori
cytotox
effect
lycorin
activ
leukemia
turn
revers
effect
lycorin
may
produc
mitogen
activ
anim
cell
lycorin
pseudolycorin
exert
antivir
effect
sever
rnaand
dnacontain
virus
antivir
activ
observ
test
flavivirus
slightli
lesser
degre
bunyavirus
lycorin
pseudo
lycorin
also
show
inhibitori
activ
punta
toro
rift
valley
fever
virus
low
select
lycorin
turn
act
antisarscov
sever
acut
respiratori
syndromeassoci
coronaviru
show
pro
nounc
activ
poliomyel
coxsacki
herp
type
virus
possess
high
antiretrovir
activ
accompani
low
therapeut
indic
relationship
structur
mechan
activ
studi
herp
simplex
viru
suggest
alkaloid
may
eventu
prove
antivir
agent
hexahydroindol
ring
two
functio
nal
hydroxyl
group
activ
found
due
inhibit
multipl
direct
inactiv
extracellular
virus
mechan
antivir
effect
partial
explain
block
viral
dna
polymeras
activ
lycorin
appreci
inhibitori
activ
acetylcholinesteras
cholinesteras
activ
appear
associ
two
free
hydroxyl
group
present
alkaloid
structur
type
higher
cholinesteras
activ
assoanin
oxoassoanin
respect
lycorinetyp
alkaloid
could
explain
aromat
ring
c
give
certain
planar
molecul
anoth
alkaloid
galanthin
exhibit
power
cholinerg
activ
therefor
attract
much
interest
treat
ment
myasthenia
gravi
myopathi
diseas
central
nervou
system
caranin
pseudolycorin
ungiminorin
particular
ung
eremin
also
show
inhibitori
effect
acetylcholinesteras
lycorin
analges
aspirin
hypotens
caranin
galanthin
analges
activ
exhibit
amaryllidacea
alkaloid
attribut
resembl
morphin
codein
skeleton
lycorin
also
antiarrhythm
action
lycorin
hydro
chlorid
strong
broncholyt
fact
lycorin
show
relax
effect
isol
epinephrineprecontract
pulmonari
arteri
increas
contractil
rate
isol
perfus
heart
effect
mediat
stimul
badrenerg
receptor
lycorin
also
strong
inhibitori
effect
parasit
encephalitozoon
intestinali
develop
antifung
activ
candida
albican
addit
lycorin
antifeed
antimalari
emet
antiinflammatori
antiplatelet
well
antifertil
acti
viti
galanthin
turn
show
mild
vitro
activ
tripanosoma
brucei
rhodesiens
plasmodium
falciparum
report
alkaloid
seri
homolycorin
homolycorin
possess
high
antiretrovir
activ
accompani
low
therapeut
indic
hippeastrin
turn
display
anti
viral
activ
herp
simplex
type
dubiusin
homolycorin
lycorenin
hypotens
effect
arteri
pressur
normotens
rat
lycorenin
also
show
vasodepressor
action
ascrib
maint
nanc
aadrenerg
block
action
produc
bradycardia
modifi
vagal
activ
anoth
featur
lycorenin
analges
activ
homolycorin
masonin
inductor
delay
hyper
sensit
anim
hippeastrin
turn
show
antifung
activ
c
albican
also
possess
weak
insect
antifeed
activ
hemanthamin
hemanthidin
crinamin
maritidin
papyramin
display
pronounc
cell
growth
inhibitori
activ
va
rieti
tumor
cell
rauscher
viral
leukemia
molt
lymphoma
mous
melanoma
human
hepatoma
hela
lncap
human
prostat
cancer
ht
alkaloid
name
crinamin
hema
nthamin
papyramin
also
present
cytotox
effect
nontumor
fib
roblast
lmtk
cell
mechan
action
hemanthamin
thought
inhibit
protein
synthesi
block
peptid
bond
mation
step
peptidyl
transferas
center
ribosom
subunit
hemanthamin
hemanthidin
also
display
pronounc
cell
growth
inhibitori
activ
parent
multidrug
resist
mous
lymphoma
cell
line
describ
lycorin
crinamin
turn
show
inhibitori
effect
nitric
oxid
product
induct
induc
nitric
oxid
synthas
no
lipopolysaccharideactiv
macro
phage
antimalari
activ
strain
chloroquinesensit
p
falcipa
rum
observ
hemanthamin
hemanthidin
attribut
methylenedioxybenzen
part
molecul
tertiari
nitrogen
without
methyl
crinamin
also
exhibit
moder
antimalari
activ
hemanthidin
also
work
vitro
trypanosoma
brucei
rhodesiens
lesser
extent
trypanosoma
cruzi
vittatin
antibacteri
activ
gramposit
staphylococcu
aureu
gramneg
e
coli
alkaloid
crinamin
show
strong
activ
bacillu
subtili
aureu
like
lycorin
hemanthidin
stronger
analges
antiinflam
matori
activ
aspirin
vittatin
found
potenti
analges
effect
morphin
moreov
alkaloid
seri
hemanthamin
papiramin
hypotens
effect
hemanthamin
show
strong
antiretrovir
activ
tazettin
mildli
activ
certain
tumor
cell
line
slight
cytotox
test
fibroblast
lmtk
cell
line
tazettin
also
display
weak
hypotens
antimalari
activ
interact
dna
chemic
labil
precursor
pretazettin
far
interest
due
antivir
anticanc
activ
fact
pre
tazettin
stereochem
rearrang
tazettin
biolog
activ
precursor
larg
extent
reduc
pretazettin
show
cytotox
fibroblast
lmtk
cell
line
inhibit
hela
cell
growth
therapeut
effect
advanc
rauscher
leukemia
ehrlich
ascit
carcinoma
spontan
akr
lymphocyt
leukemia
lewi
lung
carcinoma
one
activ
amaryl
lidacea
alkaloid
lymphoid
cell
use
combin
dnabind
alkyl
agent
treat
rauscher
leukemia
viru
fact
pretazettin
strongli
inhibit
activ
revers
transcriptas
variou
oncogen
virus
bind
enzym
inhibit
growth
rauscher
viru
cellular
protein
synthesi
eukaryot
cell
mechan
affect
dna
rna
synthesi
even
though
pronounc
dnabind
activ
pretazettin
also
shown
activ
select
rnacontain
flavovirus
japanes
enceph
yellow
fever
dengu
bunyavirus
punta
toro
rift
valley
fever
organ
cultur
also
possess
pronounc
activ
herp
simplex
type
viru
activ
may
reflect
gener
abil
inhibit
protein
synthesi
viral
replic
narciclasin
antimitot
antitumor
alkaloid
affect
cell
divis
metaphas
stage
inhibit
protein
synthesi
eukaryot
ribo
some
directli
interact
subunit
inhibit
peptid
bond
format
prevent
bind
termin
end
donor
substrat
peptidyl
transferas
center
also
retard
dna
synthesi
inhibit
calprotectininduc
cytotox
lower
concen
tration
lycorin
peculiar
effect
narciclasin
seem
aris
function
group
conform
freedom
cring
group
believ
import
biolog
activ
alkaloid
relat
pancratistatin
one
import
antineoplast
amaryllidacea
alkaloid
show
promis
anticanc
agent
inhibit
hela
cell
growth
antileukem
properti
activ
varieti
tumor
cell
human
murin
lymphocyt
leukemia
larynx
cervix
carcinoma
ehrlich
tumor
cell
effect
observ
toward
solid
tumor
show
similar
cytotox
antitumor
activ
narciclasin
narciclasin
prophylact
effect
adjuv
arthriti
model
rat
significantli
suppress
degre
swell
adjuvanttr
well
untreat
feet
alkaloid
also
activ
corynebacterium
fascian
inhibit
pathogen
yeast
cryptococcu
neoforman
modif
like
inhibit
growth
pathogen
bacterium
neisseria
gonorrhoea
antivir
activ
observ
rnacontain
flavivirus
bunyavirus
plant
level
narciclasin
potent
inhibitor
show
broad
rang
effect
includ
abil
inhibit
seed
germin
seedl
growth
plant
dosedepend
manner
interact
hormon
physiolog
respons
thu
acid
overcom
inhi
bition
elong
wheat
coleoptil
section
caus
narciclasin
addit
narciclasin
suppress
gibberellininduc
aamylas
product
barley
seed
cytokinininduc
expans
green
excis
radish
cotyledon
like
lycorin
narciclasin
also
inhibit
ascorb
acid
biosynthesi
narciclasin
present
daffodil
mucilag
delay
tepal
senesc
cut
iri
flower
attenu
proteas
activ
turn
appar
relat
inhibit
protein
synthesi
involv
senesc
organel
level
narciclasin
inhibit
isocitr
lyas
icl
activ
glyoxysom
hydroxypyruv
reductas
hpr
activ
peroxysom
also
block
mation
chloroplast
markedli
reduc
chlorophyl
content
lightgrown
wheat
seedl
probabl
due
inhibit
format
acid
essenti
chlorophyl
precursor
format
lightharvest
chlorophyl
ab
bind
protein
lhcp
also
inhibit
alkaloid
alkaloid
seri
trisphaeridin
possess
high
antiretrovir
activ
accompani
low
therapeut
indic
ismin
turn
show
signific
hypotens
effect
arteri
pressur
normo
tensiv
rat
cytotox
molt
lymphoid
lmtk
fibroblast
cell
line
littl
inform
montaninetyp
alkaloid
data
pancracin
show
antibacteri
activ
aureu
pseudomona
aeroginosa
well
weak
activ
tripanosoma
brucei
rhodesiens
cruzi
p
falciparum
galanthamin
origin
isol
galanthu
nivali
l
longact
select
revers
competit
inhibitor
acetylcho
linesteras
enzym
respons
degrad
acetylcholin
neuromuscular
junction
peripher
central
cholinerg
synaps
para
sympathet
target
organ
galanthamin
abil
cross
bloodbrain
barrier
act
within
central
nervou
system
bind
base
activ
site
gorg
acetylcholinesteras
interact
cholinebind
site
acylbind
pocket
number
moder
toweak
interact
protein
addit
galanthamin
stimu
late
preand
postsynapt
nicotin
receptor
turn
increas
releas
neurotransmitt
thu
directli
stimul
neuron
function
also
suggest
stimul
nicotin
receptor
protect
apoptosi
duce
bamyloid
toxic
dual
mode
action
coupl
evid
galanthamin
reduc
side
effect
make
promis
candid
treatment
nervou
diseas
paralysi
syndrom
schizophrenia
form
dementia
well
alzheim
diseas
galanthamin
noteworthi
pharmacolog
action
includ
abil
amplifi
nervemuscl
transfer
affect
membran
ionic
proc
ess
also
known
caus
bradycardia
atrioventricular
conduct
disturb
long
use
revers
agent
anesthet
practic
inhibit
traumat
shock
patent
use
treatment
nicotin
depend
besid
galanthamin
act
mild
analept
show
analges
power
strong
morphin
compens
effect
opiat
respir
reliev
jet
lag
fatigu
syndrom
male
impot
alcohol
depend
appli
eye
drop
reduc
intraocular
pressur
also
act
hypotens
weak
antimalari
activ
present
prevent
cur
treatment
avail
alzheim
diseas
leav
symptomat
relief
offer
achei
therapi
approv
therapeut
option
owe
rel
lack
altern
treatment
galanthamin
reason
approxim
ideal
concept
symptomat
alzheim
diseas
therapi
galanthamin
hydrobromid
thirdgener
cholinesteras
inhibitor
use
alzheim
diseas
offer
superior
pharmacolog
profil
increas
toler
compar
origin
acetyl
cholinesteras
inhibitor
physostigmin
tacrin
galanthamin
effect
well
toler
result
shortterm
improv
cognit
func
tion
daili
life
activ
patient
mild
moder
symptom
howev
longterm
benefit
beyond
month
question
persist
elev
acetylcholin
may
lead
overstimul
nicotin
muscarin
acetylcholin
receptor
former
caus
receptor
desen
sitiz
latter
potenti
caus
increas
frequenc
cholinerg
side
effect
safeti
profil
galanthamin
well
clinic
effect
demonstr
largescal
clinic
trial
broadli
speak
develop
galanthamin
wide
use
alzheim
drug
divid
three
main
period
earli
develop
eastern
europ
use
treatment
poliomyel
preclin
develop
clinic
develop
galanthamin
hydrobromid
first
use
bulgarian
russian
research
exploit
varieti
clinic
purpos
use
clinic
postsurgeri
revers
tubocurarineinduc
muscl
relax
treat
postpolio
paralysi
myasthenia
gravi
neuromuscular
diseas
well
traumat
brain
injuri
earli
soviet
research
demonstr
galanthamin
could
revers
scopolamineinduc
amnesia
mice
find
demonstr
man
year
later
howev
alkaloid
appli
alzheim
diseas
long
wide
accept
cholinerg
hypothesi
first
postul
research
western
europ
switch
attent
galanthamin
abil
penetr
bloodbrain
barrier
specif
augment
central
cholinerg
function
led
clinic
trial
galanthamin
treatment
alzheim
diseas
sanochemia
pharmazeutika
austria
first
launch
galanthamin
nivalin
strictli
limit
avail
meant
intern
pharma
ceutic
commun
adopt
caution
approach
sanochemia
pharmazeutika
develop
method
synthet
produc
compound
later
galanthamin
codevelop
shire
pharmaceut
great
britain
janssen
research
foundat
belgium
launch
galanthamin
reminil
mani
countri
renew
interest
reflect
increas
number
scientif
review
concern
exclus
galanthamin
deriv
sanguinin
potent
acetylcholinesteras
inhibitori
activ
galanthamin
due
extra
hydroxyl
group
avail
potenti
interact
acetylcholinesteras
sanguinin
turn
select
galanthamin
acetylcholinesteras
ach
vs
butyrylcholinesteras
buch
lack
ach
inhibitori
activ
lycoramin
epinorlicoramin
could
due
occurr
doubl
bond
ring
c
allow
alkaloid
spatial
configur
activ
alkaloid
seri
narwedin
biogenet
precursor
galanthamin
studi
respiratori
stimul
increas
amplitud
decreas
frequenc
cardiac
contract
would
therefor
valu
reduc
blood
loss
surgeri
also
inhibit
action
narcot
hypnot
increas
analges
effect
morphin
well
pharmacolog
effect
caffein
carbazol
arecolin
nicotin
cheryllin
deriv
group
sever
po
tential
medicin
properti
includ
weak
acetylcholinesteras
inhibitori
activ
mesembrenon
turn
mildli
activ
molt
lymphoid
nontumor
fibroblast
lmtk
cell
moder
hypotens
effect
arteri
pressur
interact
slightli
dna
